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Background: Prolonged exercise, such as marathon running, has been associated with an increase in respiratory
mucosal inflammation. The aim of this pilot study was to examine the effects of Montmorency cherry juice on
markers of stress, immunity and inflammation following a Marathon.
Methods: Twenty recreational Marathon runners consumed either cherry juice (CJ) or placebo (PL) before and after
a Marathon race. Markers of mucosal immunity secretory immunoglobulin A (sIgA), immunoglobulin G (IgG),
salivary cortisol, inflammation (CRP) and self-reported incidence and severity of upper respiratory tract symptoms
(URTS) were measured before and following the race.
Results: All variables except secretory IgA and IgG concentrations in saliva showed a significant time effect (P <0.01).
Serum CRP showed a significant interaction and treatment effect (P < 0.01). The CRP increase at 24 and 48 h post-Marathon
was lower (P < 0.01) in the CJ group compared to PL group. Mucosal immunity and salivary cortisol showed no
interaction effect or treatment effect. The incidence and severity of URTS was significantly greater than baseline at
24 h and 48 h following the race in the PL group and was also greater than the CJ group (P < 0.05). No URTS were
reported in the CJ group whereas 50 % of runners in the PL group reported URTS at 24 h and 48 h post-Marathon.
Conclusions: This is the first study that provides encouraging evidence of the potential role of Montmorency cherries
in reducing the development of URTS post-Marathon possibly caused by exercise-induced hyperventilation trauma,
and/or other infectious and non-infectious factors.
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Prolonged and exhaustive exercise is often associated with
symptoms and signs of respiratory mucosal inflammation
[1, 2]. The upper respiratory tract symptoms (URTS) usually
seen following prolonged and exhaustive exercise [3, 4] have
conventionally been attributed to a transient depression
of the innate and adaptive immunity that eventually pro-
gresses into infection [5]. However, recent studies that* Correspondence: l.dimitriou@mdx.ac.uk
1London Sport Institute, Middlesex University, Allianz Park, Greenland Way,
NW4 1RLE, London, UK
Full list of author information is available at the end of the article
© 2015 Dimitiou et al.; licensee BioMed Centr
Commons Attribution License (http://creativec
reproduction in any medium, provided the or
Dedication waiver (http://creativecommons.or
unless otherwise stated.examined the aetiology of URTS following Marathon run-
ning reported that half or more than two-thirds of symp-
tomatic cases were attributable to inflammation [6] and/or
allergy [7]. This non-infectious hypothesis can be further
supported due to the fact, episodes of URTS in athletes are
not characterised by usual seasonal patterns and show an
unusual short-term duration [8]. Exercise-induced airway
inflammation, common in endurance athletes [1, 9-11] can
be mediated by a number of factors including the synergistic
effect of hyperventilation trauma [2, 12], oxidative stress
[13] and inhaled allergens and pollutants [7, 10, 14].
Exercise has shown to up-regulate the chemotactic cyto-
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of bronchoconstriction and possibly imitating symptoms
that resemble respiratory infections [8]. For example,
interleukin-8 (IL-8) has been implicated in pulmonary
inflammation and hyper-responsiveness under acute oxi-
dative stress [16, 17]. Previous studies have shown a unani-
mous increase in IL-8 following prolonged and exhaustive
exercise [18, 19]. IL-8 is known to be a potent mediator of
chemotaxis, and activates neutrophils resulting in the gen-
eration of reactive oxygen species (ROS) [20], which might
lead to pulmonary inflammation and trauma [13]. Neutro-
phils increase markedly post-Marathon [19, 21], and pul-
monary inflammation is characterised by the migration and
activation of neutrophils into the airways [22]. Increased
neutrophils in induced sputum post-Marathon have been
reported in healthy athletes [1].
Tart Montmorency cherries are purported to be high
in numerous phytochemicals, such as anthocyanins, and
other polyphenolic compounds such as quercetin that
possess anti-inflammatory and anti-oxidative properties
[23, 24]. Growing interest in these functional foods has
gained momentum in recent years and there is a mount-
ing body of evidence to suggest Montmorency cherries
can facilitate exercise recovery [24-28]; this is likely
attributable to the increased bioavailability of these
anti-inflammatory and anti-oxidative phytochemicals fol-
lowing ingestion [29, 30]. In a recent addition to the lit-
erature, Bell et al. [24] showed that in trained cyclists,
consumption of a Montmorency cherry concentrate (in
comparison to a calorific matched placebo) resulted in a
reduction in lipid hyperoxides and a concomitant reduc-
tion in inflammation (IL-6 and C-reactive protein) fol-
lowing repeated days strenuous cycling. Additionally,
polyphenols such as quercetin (also found in Montmo-
rency cherries), modulate the expression of transcription
nuclear factor-kappa B (NF-kappaB), [31, 32], which may
in turn decreased the exercised-induced IL-6 production
by an attenuation of cytokine transcription for IL-6. Previ-
ous studies have also shown these polyphenols to reduce
other inflammatory biomarkers such as tumor necrosis
factor alpha [32, 33], and macrophage inflammatory pro-
tein [33]. Consequently, it is conceivable that the anti-
inflammatory and anti-oxidative potential of Montmo-
rency cherries could attenuate the exercise-induced ‘stress’
response, immunity and URTS. Therefore, the aim of the
current pilot study was to explore the possibility that
Montmorency CJ supplementation before and following
Marathon running could modulate markers of stress, im-
munity and self-reported upper respiratory tract symptoms.
Methods
Participants
Twenty Marathon runners (characteristics presented in
Table 1) volunteered to participate. The subjects werethe same cohort as those from previously published
work [30] that examined the impact of Montmorency
cherry juice blend on recovery following Marathon run-
ning. Eighteen completed the 2008 London Marathon
(temp: 7 °C, humidity: 56 %, wind speed: 4 km/h) and
remaining two completed the same distance in West
London two weeks later in similar conditions (temperature:
7 °C, humidity: 50 %, wind speed: 12 km/h). Following
completion of written informed consent, all participants
were asked to refrain from taking nutritional supple-
ments, pharmacological interventions and strenuous
exercise (other than completing training runs prior to
the Marathon) for the duration of the study. All proce-
dures were granted ethical approval from the Institu-
tional Research Ethics Committee, in accordance with
the Helsinki Declaration.
Experimental overview
Participants were randomly assigned to either a placebo
(PL) or cherry juice blend (CJ) group based upon pre-
dicted Marathon finish time. Possible sex differences in
response to Marathon running were controlled by balan-
cing the number of male and female participants in each
group (3 CJ, 4 PL). Markers of stress, inflammation, mu-
cosal immunity and upper respiratory tract symptoms
were measured on four occasions; the day before the
Marathon, immediately after, and at 24 h and 48 h after
the Marathon. Following an initial visit to the laboratory,
six days prior to the Marathon, participants were allo-
cated to treatment groups and were instructed to take
the supplement for five days prior to, the day of the
Marathon and for the 48 h following the Marathon (total
eight days).
Treatment groups
The CJ group consumed 2 servings x 236 ml (taken morn-
ing and afternoon) of a fresh pressed blend (Cherrypharm
Inc., Geneva, New York, USA) of tart Montmorency CJ
combined with proprietary apple juice (which the manu-
facturers add to increase palatability). According to previ-
ous work [26, 28] each serving equated to 50-60 whole
cherries and contained ~600 mg of phenolic compounds
of which at least 40 mg were anthocyanins. The remaining
compounds consisted of flavonoids such as quercetin,
kaempferol and isoramnetin; flavanols such as catechin
and epicatechin procyanidins and phenolic acids such as
neochlorogenic acid, chlorogenic acid and ellagic acid.
The estimated oxygen radical absorbance capacity
(ORAC) value per serving was estimated as 55 mMol/L
Trolox equivalents [26]. The PL group consumed 2 x
236 ml per day of a pre-made, sugar-free fruit flavored
drink (Summer Fruits Squash, Tesco, UK) of similar ap-
pearance, but lacking the phytonutrient content and
contained only a trace of anthocyanin.
Table 1 Study’s participant’s characteristics. No statistical differences found between groups for any variable; Values are mean ± SD
Group Gender (M/F) Age (years) Stature (m) Mass (kg) Predicted time
(h:min:ss)
Actual time
(h:min:ss)
Highest weekly
mileage
Longest training
run (miles)
Past
Marathons
CJ 7/3 37 ± 13 1.77 ± 0.06 72.9 ± 9.8 3:41:00 ± 0:26:01 3:48:04 ± 0:48:58 33.0 ± 11.6 20.9 ± 2.6 7 ± 9
PL 6/4 38 ± 5 1.75 ± 0.09 73.8 ± 9.5 3:56:40 ± 0:40:37 4:15:48 ± 1:01:22 31.7 ± 8.2 19.3 ± 3.1 2 ± 7
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symptoms (URTS)
Runners were asked to report (adapted from Reid et al.,
[34]) any incidence of cough; colored discharge; sore
throat; watery eyes; nasal symptoms (congestion and/or
discharge); sneezing and rate their severity on a 5-point
Likert scale anchored by 1 (very mild) to 5 (very strong)
as described by Nieman et al. [35]. Participants with two
or more of the above symptoms present for a minimum
of two consecutive days in the study period were identi-
fied as symptomatic [36].Saliva sampling procedures
Ten minutes before saliva collection, participants rinsed
their mouths thoroughly for 30 s with water [37], and
swallowed any saliva present in the mouth. Participants
then actively swabbed their mouths, around their gums,
tongue and inside their cheek, with an oral fluid collector
(OFC; IPRO Interactive, Oxfordshire, UK) consisting of a
synthetic polymer based material on a polypropylene tube,
to collect saliva. The OFC has a volume adequacy indica-
tor, giving a clear colour change when 1.0 mL (±20 %) is
collected. Analyte recovery from the OFC is in excess of
85 % within 1 min of gentle shaking [38]. Saliva sample
collection time was recorded (s), to facilitate the calcula-
tion of saliva flow rate (Salfr), as described elsewhere [37],
and was dependent on the time required by each individ-
ual to collect ~0.5 ml of saliva. The OFC was then inserted
immediately in to an extraction buffer containing sodium
phosphate, salts, detergents and preservatives designed to
prevent growth of microorganisms and facilitate extrac-
tion of proteins and small mass molecular analytes from
the swab. Samples were frozen immediately and stored
at—20C until analysis [37].Salivary analyses
Secretory immunoglobulin A (sIgA), salivary immuno-
globulin G (IgG) and salivary cortisol were determined
in duplicate from the same sample, using enzyme immuno-
assay (EIA) test kits (IPRO Interactive Ltd., Oxfordshire,
England), in an automated analyser (Tecan Nanoquant).
The assay ranges were: sIgA 18.75–600 μg/mL; IgG
2.0–120 μg/mL; and cortisol 0.25–32.0 ng/mL. The intra-
assay CV was: sIgA < 5.77 %; IgG < 3.37 %; cortisol < 7.85 %.
The inter-assay CV was: sIgA < 12.52 %; IgG <10.77 %;and cortisol < 13.10 %. sIgA data is expressed as concen-
tration (μg/mL) and as output/secretory rate (μg/min).
Serum analyses
Serum C-reactive protein was determined using an auto-
mated analyser (c800, Abbott Architect). These data are
published elsewhere [28], but are presented here as a
global index of the exercise-induced inflammatory re-
sponse. Normal ranges for this assay are <0.8 mg.L-1with
minimum detection concentration (mdc) 0.3 mg.L-1. The
CV of the intra-sample variability was 3.7 %. Samples
with values below the mdc for any of the above markers
were reported as equal to 0.5 mdc [39].
Statistical analyses
Statistical analyses were performed using SPSS version
19.0. Values are reported as means and ± SD. An alpha
level of 0.05 was chosen a priori. Independent T-tests
were used to assess for demographic characteristics, pre-
dicted and actual Marathon time, Marathon history and
training mileage leading up to the race between treat-
ment groups. Differences between treatments were ana-
lysed using a 2 x 4 mixed model analyses of variance
ANOVA with Treatment: CJ versus PL and Time as
the within subject factor (pre, post, 24 h and 48 h).
Mauchly’s sphericity test was used to assess if the vari-
ances of the differences between conditions were homo-
geneous. Simple main effects analyses were calculated
for significant interaction effects between treatment and
time. Violations of the sphericity assumption were cor-
rected using the Greenhouse-Geisser estimate.
Results
There were no differences between groups for age, stat-
ure, mass, previous Marathon history, weekly mileage,
longest single training run, predicted and actual Mara-
thon time (Table 1). Post-race body mass was lower than
body mass the day before the race (P < 0.001) with simi-
lar declines in the CJ group and PL group (1.2 ± 1.3 kg
vs. 1.7 ± 1.5 kg, respectively).
Secretory IgA concentration showed no time or inter-
action effects (Fig. 1A). Conversely, there was a time ef-
fect for output (F(3,54) = 7.560, P < 0.001, ηp
2 = 0.296) and
decreased immediately post-race in both groups when
compared to pre-race levels, and returned to baseline
by 24 h post-race. No treatment or interaction effects
Fig. 1 Selected markers of mucosal immunity, stress, inflammation and upper respiratory symptoms for the cherry juice and placebo groups before
and up to 48 h following a Marathon race (Mean ± SD; n = 10 per group). sIgA concentration (panel A); sIgA output (panel B); IgG concentration
(panel C); salivary cortisol (panel D); serum C-reactive protein concentration (CRP, panel E); severity of upper respiratory tract symptoms (URTS,
panel F). *Significantly lower serum CRP and severity of URTS in the CJ than the PL group at 24 h and 48 h post-Marathon race (P < 0.05).
†Significant time effect
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concentration showed no time, treatment or interaction
effects (Fig. 1C).
Salivary Cortisol showed a significant time effect and
was elevated immediately post-race in both groups,
(F(1,18) = 26.291, P < 0.001, ηp
2 = 0.594) when compared to
pre-race levels, and returned to baseline by 24 h post-
race. No significant treatment or treatment by time
interaction effects were observed (see Fig. 1D).
Serum CRP showed a significant time effect (F(3,54) =
247.138, P < 0.001, ηp
2 = 0.932), a treatment by time inter-
action effect (F(3,54) = 10.667, P < 0.01, ηp
2 = 0.372), and atreatment effect F(1,18) = 12.920, P < 0.01, ηp
2 = 0.418).
The increase in CRP at 24 and 48 h post-Marathon was
significantly lower (F(1,18) = 12.14, P < 0.01 and F(1.18) =
9.88, P < 0.01, respectively) in the CJ group compared to
PL group (see Fig. 1E).
The incidence and severity of URTS showed a time ef-
fect (F(3,54) = 6.359, P < 0.01, ηp
2 = 0.261). URTS were in-
creased at 24 h and 48 h following the race when
compared to pre-race levels in the PL group only. A
treatment (F(1,18) = 7.826, P < 0.05, ηp
2 = 0.303) and
interaction effect (F(3,54) = 6.359, P < 0.01, ηp
2 = 0.261)
was observed, whereby URTS were significantly higher
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post-race (F(1,18) = 5.44, P < 0.05) compared to CJ group
(Fig. 1F). No URTS were reported in the CJ group at 24 h
and 48 h post-Marathon as opposed to the PL group
whom 50 % (5/10) of the runners developed URTS.
Discussion
In this pilot study, we investigated the effects of a Mont-
morency tart cherry juice on markers of stress, immun-
ity, and self-reported incidence and severity of upper
respiratory tract symptoms following a Marathon. It was
hypothesised that CJ supplementation would attenuate
the cortisol and inflammatory response, reduce transient
suppression of mucosal immunity and lower the devel-
opment of URTS by protecting the respiratory tract from
symptoms associated with infectious and non-infectious
inflammatory agents following a Marathon. Despite no ap-
parent change in cortisol or mucosal immunity between
groups, runners that consumed Montmorency CJ had a
lower CRP response at 24 and 48 h post–Marathon
and had zero incidence of reported URTS up to 48 h
after the Marathon, suggesting that CJ attenuated the
exercise-induced inflammatory response and the subse-
quent development of URTS compared to the PL group
following the race.
The development of URTS observed at 24 and 48 h
post-Marathon in the PL group only, might be of a non-
infectious nature reflecting a synergistic effect of pul-
monary inflammation mediated by exercise-induced
hyperventilation trauma [2, 12], oxidative stress [13], al-
lergies [7] and air pollution [14]. A limitation with the
current study is that we did not examine the prevalence
of URTS beyond 48 h and this could be explored in fu-
ture work given that URTS might become evident well
beyond 48 h. Enhanced airway exposure to inhaled pol-
lutants and/or allergens has been associated with airway
hyper-responsiveness in many athletes of different sports
[10]. Hyperventilation can cause bronchial dehydration
injuries, excessive mucus production and/or airway
oedema [40]; symptoms that could resemble an URTI.
Airway inflammation is commonly reported in endur-
ance athletes [1, 9-11], and heavy exercise is associated
with pulmonary mucosal inflammation [2] induced by
repetitive hyperventilation, bronchial dehydration [40],
and increased airway osmolarity. Speculatively, these in
turn might stimulate the release of chemotactic factors
from bronchial epithelial cells [15], further supporting
an exercise-induced URTS development attributable to
non-infective inflammatory factors [41] in this study.
The URTS usually seen following prolonged and ex-
haustive exercise [3] have conventionally been attributed
to a transient immune depression that eventually pro-
gresses into infection [5]. However, recent studies that
examined the aetiology of URTS following Marathonrunning reported that equal or more than two-thirds of
symptomatic cases were attributable to inflammation [6]
and/or allergy [7]. In the present study, CRP was signifi-
cantly elevated in both groups but its response at 24 and
48 h following the Marathon was blunted in the CJ group
compared to the PL. This is consistent with previous stud-
ies that used cherry supplementation [24, 28, 42, 43]. Fur-
thermore, the CJ group did not report any URTS at 24
and 48 h post-Marathon as opposed to the PL group that
reported a 50 % development of URTS. Further studies are
needed to explore this in larger samples using techniques
such as endobronchial biopsies and induced bronchoalve-
olar lavage fluid (BALF) to elucidate this possibility.
Findings from a previously published study that used
the same cohort [28] showed a blunted IL-6 response
immediately post-Marathon, and lower uric acid imme-
diately and 24 h post-Marathon in the CJ group com-
pared to the PL group. The bioactive food components
(BAFC) contained in cherries have shown, in vitro, to in-
hibit cyclooxygenase (COX)-1 and COX-2 enzyme activ-
ity, by an average of 28 % and 47 % respectively, which
is responsible for the inflammatory response [44]. A
subsequent study further supported this by showing a
COX-2 inhibitory effect of anthocyanins [45]. These
aforementioned studies and the results from the cohort
of this study suggest that the anti-inflammatory activities
in tart cherries could attenuate the exercise-induced in-
flammatory response, its exacerbation and therefore the
development of URTS. This observation adds to the
growing body of evidence that shows the potential of
tart Montmorency cherries in aiding exercise recovery
and improving health indices [23, 24, 30, 32, 46, 47].
The prevalence of allergy and atopy (sensitization to
common inhalant allergens) in long-distance runners
has been reported to be 40 % and 49 %, respectively [7,
10]. In allergic diseases associated with the respiratory
tract (i.e., asthma and rhinitis) the migration of eosino-
phils to the mucosal surfaces is enhanced [48]. The re-
spiratory tract is rich in cytokines and chemokines (e.g.,
IL-8), which in turn could activate the eosinophils and
possibly participate in the modulation of the local
immune response via degranulation [49]. Eosinophil ac-
tivation has been reported to be a crucial element in
upper and lower respiratory inflammation [50]. Exercise-
induced recruitment and degranulation of eosinophils
and basophils to the respiratory tract due to airway in-
flammation may possibly explain the exercise-induced
URTS development seen in the PL group in this study and
the increased incidence of URTI reported previously [3].
Furthermore, a more recent in vitro study showed that
the polyphenol quercetin suppresses eosinophil activation
[51], suggesting that various BAFC of cherries might
modulate eosinophil-mediated diseases, such as allergic
rhinitis and asthma, which are very common pathologies
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showed that 58 % of runners with reported URTS follow-
ing the 2010 London Marathon had allergy, as defined by
a positive Allergy Questionnaire for Athletes (AQUA) and
specific immunoglobulin E (IgE) response to various in-
halant allergens [7]. The prevalence of the reported URTS
following the 2008 London Marathon in this study were
considerably lower (25 %) than previously reported (47 %)
by Robson-Ansley et al. [7]. This difference could be
partly explained by the daily average tree pollen counts on
the day of the 2008 London Marathon that were approxi-
mately 9-fold less (Robson-Ansley et al. [7]) than those re-
ported in the 2010 Marathon. Although this suggests a
dose-dependent response between pollen counts and
URTS, the antioxidant and anti-inflammatory properties
of CJ offers a plausible explanation for the complete ab-
sence of reported URTS in the CJ group.
Pulmonary inflammation can be exacerbated by con-
current exposure to tropospheric ozone and other pol-
lutants present in Metropolitan cities [14]. Exposure to
air pollutants is greater in endurance athletes as they
train mostly outdoors, and compete in Marathons that
commonly take place in big cities. Furthermore, the
shifting from nasal to oronasal or oral breathing leads to
a greater inhalation of airborne allergens, pollutants,
antigens and untreated air [7]. Pollutants increase the
susceptibility to bacterial respiratory infections [14].
However, CJ ingestion could reduce exercise-induced URTI
susceptibility since there are several cell culture studies that
show the polyphenol quercetin to exert antipathogenic ac-
tivities against a wide variety of viruses and bacteria, and to
reduce infectivity of target cells and virus replication [52].
The results of the present study showed an absence of re-
ported URTS development in the CJ group and might sig-
nify a down-regulation of the inflammatory pathways
involved in pollutant inhalation. Furthermore, we cannot
rule out that the absence of reported URTS in the CJ group
might indicate an enhanced anti-pathogenic activity com-
pared to PL. Future studies could investigate the interaction
effect between air pollution and prolonged exhaustive exer-
cise on the incidence of respiratory symptoms and bronch-
oconstriction, and identify possible prophylactic measures
against them.
Conclusions
The results of this pilot study showed that a Montmo-
rency cherry juice blend appears to protect the URT
from inflammatory symptoms caused by infectious and
non-infectious agents, by possibly reducing the exercise-
induced pulmonary inflammation. Modulation of the
exercise-induced pulmonary inflammation by natural
plant products might represent an attractive strategy to
protect or alleviate the URT from inflammatory symp-
toms. This pilot investigation is the first to demonstratepreliminary evidence of the potential role of Montmo-
rency cherry juice in reducing the development of URTS
following long duration endurance exercise. Considering
the limited sample size and healthy state of this study’s
cohort, further studies with a larger sample size and par-
ticipants with asthma, atopy, allergic rhinitis, exercise in-
duced bronchoconstriction, airway hyper-responsiveness,
and other pulmonary pathologies could be performed to
explore the potential of cherries and other functional
foods that might exert a similar effect.
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